Nanotechnology, which has existed as a distinct field of study since the 1980s, encompasses the use of nanomaterials not only in electronics and catalysis, but also in biomedical research, such as drug delivery, bioimaging, biomedical diagnosis, and tissue engineering. The application of nanoscience in pharmacy and the manufacturing of drug delivery, diagnostic, imaging, and biosensor devices has the potential to have a significant impact on human health. Nanocarriers can increase blood circulation time by preventing opsonization and uptake by phagocytes, which improves therapeutic pharmacokinetics and biodistribution. Better bio-distribution of active compounds, protection against degradation, passage, targeting, increased drug attachment, expulsion, and communication with biological barriers are all benefits of incorporating therapeutic molecules in nanocarriers.
Title : Engineered nanomaterial-mediated systemically administered m-RNA-based gene therapy directed exclusively to cancer, present successes and future prospects
A C Matin, Stanford University, United States
Title : Preparation and characterization of fibers made from PCL/PVP-ChAgG, along with exploring their potential as wound dressings
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : Liver biopsy handling of metabolic-associated fatty liver disease (mafld): The children's hospital of eastern ontario grossing protocol
Consolato M Sergi, University of Ottawa, Canada
Title : Haptoglobin-related protein without signal peptide as biomarker of renal salt wasting (HPRWSP) in hyponatremia, hyponatremia-related diseases and as new syndrome in alzheimer’s disease
John K Maesaka, NYU Langone Hospital Long Island, United States